• 1
    Andre T,Bonik C,Mounedji-Boudiaf LM, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004; 350: 2243-2251.
  • 2
    Gill S,Loprinzi CL,Sargent DJ, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 2004; 22: 1797-1806.
  • 3
    Haller DG,Catalano PJ,Macdonald JS, et al. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and II colon cancer: final report of intergroup 0089. J Clin Oncol. 2005; 23: 8671-8678.
  • 4
    Twelves C,Wong A,Nowacki MP, et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med. 2005; 352: 2696-2704.
  • 5
    Kuebler JP,Wieand HS,O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and II coon cancer: results from NSABP C-07. J Clin Oncol. 2007; 25: 2198-2204.
  • 6
    Feig BW,Curley S,Lucci A, et al. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg. 2002; 182: 707-712.
  • 7
    Redston M,Compton CC,Miedema BW, et al. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. J Clin Oncol. 2006; 24: 878-883.
  • 8
    Bilchik AJ,Hoon DS,Saha S, et al. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg. 2007; 246: 568-575.
  • 9
    Stojadinovic A,Nissan A,Protic M, et al. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg. 2007; 245: 846-857.
  • 10
    Le Voyer TE,Sigurdson ER,Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003; 21: 2912-2919.
  • 11
    Prandi M,Lionetto R,Bini A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg. 2002; 235: 458-463.
  • 12
    Swanson RS,Compton CDC,Stewart AK,Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003; 10: 65-71.
  • 13
    Bui L,Rempel E,Reeson D. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol. 2006; 93: 439-445.
  • 14
    Cserni G,Vinh-Hung V,Burzykowski T. Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol. 2002; 81: 63-69.
  • 15
    Carloss H,Huang B,Cohen A, et al. The impact of number of lymph odes removed on 5-year survival in stage II colon and rectal cancer. J Ky Med Assoc. 2006; 102: 345-347.
  • 16
    Caplin S,Cerottini JP,Bosman FT, et al. For patients with Dukes' B (TNM stage II) colorectal carcinoma, examination of 6 or fewer lymph nodes is related to poor prognosis. Cancer. 1998; 83: 666-672.
  • 17
    Law CH,Wright FC,Rapanos T, et al. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer. J Surg Oncol. 2003; 84: 120-126.
  • 18
    Cianchi F,Palomba A,Boddi V, et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg. 2002; 26: 384-389.
  • 19
    Yashimatsu K,Ishibashi K,Umehara A, et al. How many lymph nodes should be examined in Dukes' B colorectal cancer. Hepatogastroenterology. 2005; 52: 1703-1706.
  • 20
    Gumus M,Yumuk PF,Atalay G, et al. What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery? Tumori. 2005; 91: 168-172.
  • 21
    Berberoglu U. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer. Hepatogastroenterology. 2004; 51: 1689-1693.
  • 22
    Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002; 26: 179-189.
  • 23
    Sarli L,Bader G,Iusco D, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer. 2005; 41: 272-279.
  • 24
    Wong JH,Bowles BJ,Bueno R,Shimizu D. Impact of the number of negative nodes on disease-free survival in colorectal cancer patients. Dis Colon Rectum. 2002; 45: 1341-1348.
  • 25
    Ratto C,Sofo L,Ippoliti M, et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum. 1999; 42: 143-154.
  • 26
    Jestin P,Pahlman L,Glimelius B,Gunnarsson U. Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer. 2005; 41: 2071-2078.
  • 27
    Scott KW,Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg. 1989; 76: 1165-1167.
  • 28
    Institute of Medicine of the National Academies. Performance Measurement: Accelerating Improvement. Washington, DC: National Academies Press; 2006.
  • 29
    Dillman RO,Chico SD. Cancer patient survival improvement is correlated with the opening of a community cancer center: comparisons with intramural and extramural benchmarks. J Oncol Prac. 2005; 1: 84-92.
  • 30
    Schrag D,Cramer LD,Bach PB,Cohen AM,Warren JL,Begg CB. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA. 2000; 284: 3028-3035.
  • 31
    Abcarian H. Operative treatment of colorectal cancer. Cancer. 1992; 70: 1350-1354.
  • 32
    Nelson H,Petrelli N,Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2000; 93: 583-596.
  • 33
    Chang GJ,Rodriguez-Bigas MA,Skibber JM,Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007; 99: 433-441.